Tu1624: CHRONIC KIDNEY DISEASE IN HOSPITALIZED PATIENTS WITH CIRRHOSIS, A GLOBAL PERSPECTIVE
Florence Wong(University of Toronto), Jasmohan S. Bajaj(Virginia Commonwealth University), M.S. González-Huezo, Patrick S. Kamath(Mayo Clinic in Arizona), Haibing Gao, Leroy R. Thacker(Virginia Commonwealth University), Haydar Adanır(Akdeniz University), J.A. Velarde-Ruiz Velasco(Hospital Civil de Guadalajara), Bing Xu(First Affiliated Hospital of Xiamen University), Adebayo Danielle, Mingqin Lu(China Animal Health and Epidemiology Center), Xiaoping Wu, Ramazan Idılman(Ankara University), Mithun Sharma(Asian Institute of Gastroenterology), Adam Doyle, Hailemichael Desalegn(St. Paul's Hospital Millennium Medical College), Ashok Choudhury(Institute of Liver and Biliary Sciences), Aldo Torre, K. Rajender Reddy(Hospital of the University of Pennsylvania), Carlos Benítez, Sumeet K. Asrani(Baylor University Medical Center), Aabha Nagral(Jaslok Hospital), Radha K. Dhiman(Sanjay Gandhi Post Graduate Institute of Medical Sciences), Neil Rajoriya, Hiang Keat Tan, Jacqueline Córdova‐Gallardo, Peter Hayes(Centre for Inflammation Research), Dinesh Jothimani, Amey Sonavane, Coşkun Özer Demirtaş, Kessarin Thanapirom(Thai Red Cross Society), Chuanwu Zhu(The Fifth People’s Hospital of Suzhou), Hibat Allah Belimi, Xin Zheng(RMIT University), Abdullah Yıldırım, Ashish Goel, Jacob George(The University of Sydney), Qing Xie(Shanghai Jiao Tong University), Brian Bush, Caiyan Zhao(Hebei Medical University), Yongfang Jiang(Central South University), Man Su(Ankara University), Mark Topazian, Wai‐Kay Seto(State Key Laboratory of Synthetic Chemistry), Shiv Kumar Sarin, Anoop Saraya(All India Institute of Medical Sciences), Aravinthan Aloysious, Ruveena Bhavani Rajaram(University of Malaya)
Cited by 0
Related Papers
Global burden of liver disease: 2023 update
|Journal of Hepatology|2023|1.9k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
|New England Journal of Medicine|2008|1.5k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
|New England Journal of Medicine|2014|1.1k